Journal article

Exposure-response analysis of venetoclax in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia: pooled results from a phase 1b study and the phase 3 MURANO study

Rong Deng, Leonid Gibiansky, Tong Lu, Xiaobin Li, Dan Lu, Chunze Li, Sandhya Girish, Jue Wang, Michelle Boyer, Noopur Shankar, Kathryn Humphrey, Kevin J Freise, Ahmed Hamed Salem, John F Seymour, Arnon P Kater, Dale Miles

Leukemia & Lymphoma | TAYLOR & FRANCIS LTD | Published : 2019


Funding Acknowledgements

The authors thank the patients, enrolling physicians, site staff, and venetoclax study teams. The authors also thank Dr Mehrdad Mobasher for his valuable contributions to the manuscript. Third-party medical writing assistance was provided by Christopher Dunn and Andrew Sutton of GardinerCaldwell Communications, and was funded by F. Hoffmann - La Roche Ltd.